Factor VM - Search Results

1

Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Böttinger EP, Klotman PE, Thorgeirsson SS. Kopp JB, et al. Among authors: factor vm. Lab Invest. 1996 Jun;74(6):991-1003. Lab Invest. 1996. PMID: 8667617

2

Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

Hironaka K, Factor VM, Calvisi DF, Conner EA, Thorgeirsson SS. Hironaka K, et al. Among authors: factor vm. Lab Invest. 2003 May;83(5):643-54. doi: 10.1097/01.lab.0000067483.89649.11. Lab Invest. 2003. PMID: 12746474 Free article.

3

Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.

Kao CY, Factor VM, Thorgeirsson SS. Kao CY, et al. Among authors: factor vm. Biochem Biophys Res Commun. 1996 May 6;222(1):64-70. doi: 10.1006/bbrc.1996.0698. Biochem Biophys Res Commun. 1996. PMID: 8630075

4

Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.

Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS. Santoni-Rugiu E, et al. Among authors: factor vm. Am J Pathol. 1996 Aug;149(2):407-28. Am J Pathol. 1996. PMID: 8701981 Free PMC article.

5

Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease.

Preisegger KH, Factor VM, Fuchsbichler A, Stumptner C, Denk H, Thorgeirsson SS. Preisegger KH, et al. Among authors: factor vm. Lab Invest. 1999 Feb;79(2):103-9. Lab Invest. 1999. PMID: 10068199

6

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.

Santoni-Rugiu E, Jensen MR, Factor VM, Thorgeirsson SS. Santoni-Rugiu E, et al. Among authors: factor vm. Am J Pathol. 1999 Jun;154(6):1693-700. doi: 10.1016/s0002-9440(10)65425-9. Am J Pathol. 1999. PMID: 10362794 Free PMC article.

7

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Sanderson N, et al. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2572-6. doi: 10.1073/pnas.92.7.2572. Proc Natl Acad Sci U S A. 1995. PMID: 7708687 Free PMC article.

8

Disregulation of E-cadherin in transgenic mouse models of liver cancer.

Calvisi DF, Ladu S, Conner EA, Factor VM, Thorgeirsson SS. Calvisi DF, et al. Among authors: factor vm. Lab Invest. 2004 Sep;84(9):1137-47. doi: 10.1038/labinvest.3700147. Lab Invest. 2004. PMID: 15220935 Free article.

9

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

Böttinger EP, Factor VM, Tsang ML, Weatherbee JA, Kopp JB, Qian SW, Wakefield LM, Roberts AB, Thorgeirsson SS, Sporn MB. Böttinger EP, et al. Among authors: factor vm. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5877-82. doi: 10.1073/pnas.93.12.5877. Proc Natl Acad Sci U S A. 1996. PMID: 8650186 Free PMC article.

10

Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.

Factor VM, Kao CY, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS. Factor VM, et al. Cancer Res. 1997 Jun 1;57(11):2089-95. Cancer Res. 1997. PMID: 9187100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters